ACHE and Alzheimer disease: In this approach, AChE represents the main target due to the fact that the hydrolysis of acetylcholine is its physiological role, but with the progression of AD, the ratio of AChE and BChE levels change in favor of BChE, so the inhibition of BChE represents a promising strategy for the treatment of AD in advanced stages of the disease [22,25,26].